Quinoxaline derivatives having antiviral activity
US7189724B2 · kind B2 · utility
38Cited by
5References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2004 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Dec 26, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides substituted quinoxalines having the general formulaswhere R1, R2, R3, and R4 are, inter alia, alkyl, aryl, or heteroaryl groups; Z is NH or O; and X is, inter alia, COOH or CONH2. The compounds of the invention have antiviral and immunomodulatory activity and are useful for treating infectious diseases, particularly viral infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.